ICU (SeaStar Medical Holding) Beneish M-Score: 0.03 (As of Jun. 26, 2026) — 99% Below Median


ICU SeaStar Medical Holding Corp ICU
29 GF Score
Price $2.98
! 4 Warning Signs
View Full Analysis

What is SeaStar Medical Holding Beneish M-Score?

SeaStar Medical Holding ICU -3.40% 29 Beneish M-Score is 0.03 as of Jun. 26, 2026, which is 99% below its 10-year median of 4.68. GuruFocus rates ICU with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 831 Biotechnology companies, SeaStar Medical Holding ranks worse than 83.51% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 0.03 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for SeaStar Medical Holding's Beneish M-Score or its related term are showing as below:

ICU' s Beneish M-Score Range Over the Past 10 Years
Min: 0.03   Med: 4.68   Max: 7.76
Current: 0.03

During the past 6 years, the highest Beneish M-Score of SeaStar Medical Holding was 7.76. The lowest was 0.03. And the median was 4.68.


SeaStar Medical Holding Beneish M-Score Historical Data

* Premium members only.

The historical data trend for SeaStar Medical Holding's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SeaStar Medical Holding Beneish M-Score Chart

SeaStar Medical Holding Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 4.68

SeaStar Medical Holding Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 7.76 4.68 0.03

ICU vs MBRX, LEXX, INTI: Beneish M-Score Comparison

For the Biotechnology subindustry, SeaStar Medical Holding's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaStar Medical Holding Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's Beneish M-Score falls into.


ICU
29GF Score
SeaStar Medical Holding Corp ICU
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SeaStar Medical Holding Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SeaStar Medical Holding for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.485+0.528 * 1.074+0.404 * 0.414+0.892 * 3.3551+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.2104+4.679 * 0.159016-0.327 * 0.3787
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $0.18 Mil.
Revenue was 0.495 + 0.42 + 0.183 + 0.338 = $1.44 Mil.
Gross Profit was 0.449 + 0.408 + 0.169 + 0.311 = $1.34 Mil.
Total Current Assets was $10.76 Mil.
Total Assets was $11.26 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $5.86 Mil.
Total Current Liabilities was $3.95 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -3.521 + -2.904 + -3.472 + -2.002 = $-11.90 Mil.
Non Operating Income was 0 + 0 + 0 + 0.016 = $0.02 Mil.
Cash Flow from Operations was -2.761 + -4.094 + -3.844 + -3.007 = $-13.71 Mil.
Total Receivables was $0.11 Mil.
Revenue was 0.293 + 0.067 + 0.068 + 0 = $0.43 Mil.
Gross Profit was 0.293 + 0.067 + 0.068 + 0 = $0.43 Mil.
Total Current Assets was $6.78 Mil.
Total Assets was $7.60 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $8.30 Mil.
Total Current Liabilities was $7.03 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.179 / 1.436) / (0.11 / 0.428)
=0.124652 / 0.257009
=0.485

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.428 / 0.428) / (1.337 / 1.436)
=1 / 0.931058
=1.074

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (10.764 + 0) / 11.263) / (1 - (6.784 + 0) / 7.597)
=0.044304 / 0.107016
=0.414

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1.436 / 0.428
=3.3551

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 0)) / (0 / (0 + 0))
= /
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5.86 / 1.436) / (8.303 / 0.428)
=4.08078 / 19.399533
=0.2104

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 3.948) / 11.263) / ((0 + 7.032) / 7.597)
=0.350528 / 0.925629
=0.3787

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-11.899 - 0.016 - -13.706) / 11.263
=0.159016

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SeaStar Medical Holding has a M-score of 0.03 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.03 mean?
SeaStar Medical Holding (ICU) has a Beneish M-Score of 0.03 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SeaStar Medical Holding and its competitors. This is 99% below median its historical median of 4.68. Over the past decade, SeaStar Medical Holding's Beneish M-Score has ranged from 0.03 to 7.76. According to the industry distribution chart, SeaStar Medical Holding ranks #694 out of 831 companies in the Biotechnology industry, placing it in the top 83.5%.
Is SeaStar Medical Holding's Beneish M-Score too high?
SeaStar Medical Holding's current Beneish M-Score of 0.03 is 99% below median its 10-year median of 4.68. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 7.76. Based on the distribution chart, SeaStar Medical Holding ranks #694 out of 831 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SeaStar Medical Holding has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does SeaStar Medical Holding's Beneish M-Score compare to MBRX and LEXX?
According to the Biotechnology industry distribution chart, SeaStar Medical Holding ranks #694 out of 831 companies for Beneish M-Score. This places SeaStar Medical Holding in the lower half of its industry. Historically, SeaStar Medical Holding's own Beneish M-Score has ranged from 0.03 to 7.76 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SeaStar Medical Holding and its competitors. SeaStar Medical Holding's current Beneish M-Score is 0.03, which is 99% below median its own 10-year median of 4.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SeaStar Medical Holding stock overvalued right now?
SeaStar Medical Holding (ICU) has a current Beneish M-Score of 0.03. The current Beneish M-Score is 0.03, which is 99% below median its 10-year median of 4.68. SeaStar Medical Holding's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For SeaStar Medical Holding (ICU), the current Beneish M-Score is 0.03 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SeaStar Medical Holding Business Description

Address 3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
29GF Score

Get the complete analysis for ICU

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.98
Price